GlassScriptPhysician profile
Lensey C Scott
NPI 1225126626
$13,543.70
in general payments reported to CMS, 2019-2025
48 companies · $1,014 in 2025
The $1,014 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,839 · 2020: $393 · 2021: $1,894 · 2022: $1,300 · 2023: $1,294 · 2024: $809 · 2025: $1,014.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,017 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,017.26 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $2,529.52 | 2019-2025 | (Ck4) Mcot, Ecc Solutions, Extended Holter |
| Angiodynamics, INC. | $1,429.56 | 2019-2021 | |
| Ekos Corporation | $1,408.58 | 2019 | |
| Novartis Pharmaceuticals Corporation | $1,276.33 | 2019-2025 | Leqvio |
| Boston Scientific Corporation | $929.32 | 2019-2025 | Eluvia, Cds - Mct/Cem Monitoring, Opticross |
| Shockwave Medical, INC | $570.99 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Pfizer INC. | $485.93 | 2019-2025 | |
| Amgen INC. | $473.02 | 2019-2025 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $455.08 | 2019-2023 | Jardiance |
| Janssen Pharmaceuticals, INC | $447.73 | 2019-2024 | Xarelto |
| Actelion Pharmaceuticals US, INC. | $416.89 | 2019-2025 | Uptravi, Opsumit |
| Astrazeneca Pharmaceuticals LP | $255.33 | 2019-2022 | |
| Amarin Pharma, INC. | $204.45 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $202.38 | 2021-2025 | Verquvo |
| Avinger INC. | $200.41 | 2020-2023 | Pantheris |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $189.05 | 2019-2024 | Camzyos, Eliquis |
| Irhythm Technologies, INC. | $174.08 | 2019-2022 | |
| Penumbra, INC. | $166.09 | 2025 | Indigo System |
| Sanofi-Aventis U.S. LLC | $164.98 | 2019-2023 | |
| Medtronic, INC. | $151.28 | 2021 | |
| Astellas Pharma US INC | $123.10 | 2019 | |
| Abbott Laboratories | $116.36 | 2021-2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Stryker Corporation | $112.45 | 2025 | Flowtriever, Clottriever Bold Catheter |
| Abiomed | $95.66 | 2020-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $84.11 | 2019-2023 | |
| Biotronik INC. | $70.29 | 2019-2022 | |
| Terumo Medical Corporation | $68.76 | 2019-2025 | Metacross Otw, R2p Misago |
| Celonova Biosciences, INC. | $66.69 | 2020 | |
| Alnylam Pharmaceuticals INC. | $62.43 | 2025 | Amvuttra |
| Baxter Healthcare | $60.81 | 2023-2024 | Hillrom - Cardiac Ambulatory Monitor |
| Bard Peripheral Vascular, INC. | $60.09 | 2019 | |
| Esperion Therapeutics, INC. | $55.57 | 2021-2022 | |
| Cardiovascular Systems INC. | $53.62 | 2020 | |
| Lexicon Pharmaceuticals, INC. | $48.13 | 2023-2024 | Inpefa |
| Inari Medical, INC. | $44.68 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cardiva Medical, INC. | $28.64 | 2025 | Cardiva Vascade 6/7f Vcs |
| Medtronic Vascular, INC. | $28.23 | 2019 | |
| Novo Nordisk INC | $27.61 | 2024 | Rybelsus, Ozempic, Wegovy |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $26.88 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $25.24 | 2019-2023 | Evkeeza |
| Kowa Pharmaceuticals America, INC. | $24.67 | 2021 | |
| Gilead Sciences, INC. | $24.57 | 2019 | |
| Heartflow, INC. | $24.53 | 2025 | |
| Elutia, INC. | $17.69 | 2021 | |
| Siemens Medical Solutions USA, INC. | $16.43 | 2019 | |
| Cashflow Solutions, LLC | $16.34 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Bridgebio Pharma, INC. | $16.33 | 2025 | Attruby |
| Tactile Systems Technology INC | $12.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lensey Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.